` 4551 (Torii Pharmaceutical Co Ltd) vs Nikkei 225 Comparison - Alpha Spread

4551
vs
Nikkei 225

Over the past 12 months, has significantly outperformed Nikkei 225, delivering a return of 14% compared to the Nikkei 225's 7% drop.

Stocks Performance
4551 vs Nikkei 225

Loading
4551
Nikkei 225
Add Stock

Performance Gap
4551 vs Nikkei 225

Loading
4551
Nikkei 225
Difference

Performance By Year
4551 vs Nikkei 225

Loading
4551
Nikkei 225
Add Stock

Competitors Performance
Torii Pharmaceutical Co Ltd vs Peers

Nikkei 225
4551
LLY
JNJ
NOVO B
ROG
Add Stock

Torii Pharmaceutical Co Ltd
Glance View

Market Cap
132B JPY
Industry
Pharmaceuticals

Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Intrinsic Value
4 736.45 JPY
Undervaluation 1%
Intrinsic Value
Price
Back to Top